231 related articles for article (PubMed ID: 35574284)
21. Design of an epitope-based peptide vaccine against spike protein of human coronavirus: an in silico approach.
Oany AR; Emran AA; Jyoti TP
Drug Des Devel Ther; 2014; 8():1139-49. PubMed ID: 25187696
[TBL] [Abstract][Full Text] [Related]
22. Identification and In Silico Characterization of a Conserved Peptide on Influenza Hemagglutinin Protein: A New Potential Antigen for Universal Influenza Vaccine Development.
Khalaj-Hedayati A; Moosavi S; Manta O; Helal MH; Ibrahim MM; El-Bahy ZM; Supriyanto G
Nanomaterials (Basel); 2023 Oct; 13(20):. PubMed ID: 37887946
[TBL] [Abstract][Full Text] [Related]
23. In silico design of a multi-epitope peptide construct as a potential vaccine candidate for Influenza A based on neuraminidase protein.
Behbahani M; Moradi M; Mohabatkar H
In Silico Pharmacol; 2021; 9(1):36. PubMed ID: 33987075
[TBL] [Abstract][Full Text] [Related]
24. Identification of a highly conserved H1 subtype-specific epitope with diagnostic potential in the hemagglutinin protein of influenza A virus.
Zhao R; Cui S; Guo L; Wu C; Gonzalez R; Paranhos-Baccalà G; Vernet G; Wang J; Hung T
PLoS One; 2011; 6(8):e23374. PubMed ID: 21886787
[TBL] [Abstract][Full Text] [Related]
25.
Herrera LRM; Bisa EP
Vet World; 2021 Oct; 14(10):2625-2633. PubMed ID: 34903918
[TBL] [Abstract][Full Text] [Related]
26. Imprinted Anti-Hemagglutinin and Anti-Neuraminidase Antibody Responses after Childhood Infections of A(H1N1) and A(H1N1)pdm09 Influenza Viruses.
Daulagala P; Mann BR; Leung K; Lau EHY; Yung L; Lei R; Nizami SIN; Wu JT; Chiu SS; Daniels RS; Wu NC; Wentworth D; Peiris M; Yen HL
mBio; 2023 Jun; 14(3):e0008423. PubMed ID: 37070986
[TBL] [Abstract][Full Text] [Related]
27. Designing multi-epitope mRNA construct as a universal influenza vaccine candidate for future epidemic/pandemic preparedness.
Rcheulishvili N; Mao J; Papukashvili D; Liu C; Wang Z; Zhao J; Xie F; Pan X; Ji Y; He Y; Wang PG
Int J Biol Macromol; 2023 Jan; 226():885-899. PubMed ID: 36521707
[TBL] [Abstract][Full Text] [Related]
28. B cell epitopes in the intrinsically disordered regions of neuraminidase and hemagglutinin proteins of H5N1 and H9N2 avian influenza viruses for peptide-based vaccine development.
Ramamurthy M; Sankar S; Abraham AM; Nandagopal B; Sridharan G
J Cell Biochem; 2019 Oct; 120(10):17534-17544. PubMed ID: 31111560
[TBL] [Abstract][Full Text] [Related]
29. Immunoinformatics and Reverse Vaccinology Driven Predication of a Multi-epitope Vaccine against
Hussain Z; Hayat C; Shahab M; Sikandar R; Bibi H; Kamil A; Zheng G; Liang C
Curr Pharm Des; 2023; 29(19):1504-1515. PubMed ID: 37073655
[TBL] [Abstract][Full Text] [Related]
30. Beyond the state of the art of reverse vaccinology: predicting vaccine efficacy with the universal immune system simulator for influenza.
Russo G; Crispino E; Maleki A; Di Salvatore V; Stanco F; Pappalardo F
BMC Bioinformatics; 2023 Jun; 24(1):231. PubMed ID: 37271819
[TBL] [Abstract][Full Text] [Related]
31. [Prediction of the B cell epitopes of hemagglutinin and neuraminidase of human infected avian influenza A H7N9 virus].
Li H; Hu P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Dec; 29(12):1319-21. PubMed ID: 24321078
[TBL] [Abstract][Full Text] [Related]
32. Designing multi-epitope vaccine against important colorectal cancer (CRC) associated pathogens based on immunoinformatics approach.
Motamedi H; Ari MM; Shahlaei M; Moradi S; Farhadikia P; Alvandi A; Abiri R
BMC Bioinformatics; 2023 Feb; 24(1):65. PubMed ID: 36829112
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatics characterization of Plasmodium knowlesi apical membrane antigen 1 (PkAMA1) for multi-epitope vaccine design.
Azazi A; Haron FN; Chua KH; Lim YAL; Lee PC; Chew CH
Trop Biomed; 2021 Sep; 38(3):265-275. PubMed ID: 34362869
[TBL] [Abstract][Full Text] [Related]
34. Prediction of Epitope-Based Peptide Vaccine Against the Chikungunya Virus by Immuno-informatics Approach.
Anwar S; Mourosi JT; Khan MF; Hosen MJ
Curr Pharm Biotechnol; 2020; 21(4):325-340. PubMed ID: 31721709
[TBL] [Abstract][Full Text] [Related]
35. Computational Design and Analysis of a Multi-epitope Against Influenza A virus.
Rostaminia S; Aghaei SS; Farahmand B; Nazari R; Ghaemi A
Int J Pept Res Ther; 2021; 27(4):2625-2638. PubMed ID: 34539293
[TBL] [Abstract][Full Text] [Related]
36. Prediction of Antigenic Vaccine Peptide Candidates From BfmRS Associated With Biofilm Formation in Acinetobacter baumannii.
Girija ASS
Cureus; 2023 Oct; 15(10):e47804. PubMed ID: 38022156
[TBL] [Abstract][Full Text] [Related]
37. Broadly Protective CD8
Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
J Virol; 2021 May; 95(12):. PubMed ID: 33827939
[TBL] [Abstract][Full Text] [Related]
38. Computational perspectives revealed prospective vaccine candidates from five structural proteins of novel SARS corona virus 2019 (SARS-CoV-2).
Anand R; Biswal S; Bhatt R; Tiwary BN
PeerJ; 2020; 8():e9855. PubMed ID: 33062414
[TBL] [Abstract][Full Text] [Related]
39. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
[TBL] [Abstract][Full Text] [Related]
40. Theoretical analysis of the neuraminidase epitope of the Mexican A H1N1 influenza strain, and experimental studies on its interaction with rabbit and human hosts.
Loyola PK; Campos-Rodríguez R; Bello M; Rojas-Hernández S; Zimic M; Quiliano M; Briz V; Muñoz-Fernández MA; Tolentino-López L; Correa-Basurto J
Immunol Res; 2013 May; 56(1):44-60. PubMed ID: 23371837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
